Peptide Arginases from Cryptic Pathways Install Ornithine Residues in Uncharacterized Members of Orphan RiPP Families
ChemBioChem · 2025
DOI: 10.1002/cbic.202500658 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Isabel P-M Pfeiffer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biology, University of Tübingen, Auf der Morgenstelle 8, 72076, Tübingen, Germany. Hauptthemen laut MEDLINE: Arginase, Ornithine, Peptides. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Ministry of Education and Research, Baden-Württemberg Ministry of Science, Alexander von Humboldt foundation.
Abstract (Originalsprache)
Ribosomally synthesized and post‐translationally modified peptides (RiPPs) are remarkable natural products with interesting chemical structures and potent bioactivities. RiPP pathways are abundant in all domains of life and harbor a large biosynthetic potential in the form of post‐translationally acting enzymes. A relatively small number of RiPP biosynthetic gene clusters encode peptide arginases, a recently discovered maturase family capable of hydrolyzing arginine residues of RiPP core peptides to ornithines. In this study, members of the peptide arginase family (FlmR and OhkR), which are associated with uncharacterized precursors from orphan RiPP families, are identified. In vivo and in vitro activity of FlmR and OhkR with the five associated precursor peptides (FlmA1‐3 and OhkA1‐2) is demonstrated and kinetic studies to biochemically characterize the enzymes are performed. Furthermore, in silico structural analysis with AlphaFold 3 is used to predict precursor–arginase complexes, providing insights into how peptide arginases could bind their precursor substrates. In the case of OhkA–OhkR complexes, this analysis also allows a hypothesis as to which of the arginine residues of the core peptide is modified first, which is confirmed experimentally. This detailed biochemical and structural enzyme characterization is a prerequisite for the application of peptide arginases in peptide‐based drug discovery platforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Biology, University of Tübingen, Auf der Morgenstelle 8, 72076, Tübingen, Germany.
- Functional Metabolomics Lab, University of Tübingen, Auf der Morgenstelle 24, 72076, Tübingen, Germany.
- Department of Biology, ETH Zürich, Institute of Microbiology, Vladimir-Prelog-Weg 1-5/10, 8093, Zürich, Switzerland.
ORCID-Profile: Isabel P-M Pfeiffer, Maria-Paula Schröder, Panagiota-Hanna Koutsandrea, Giovanni A Vitale, Daniela Herrera-Rosero, Christian Geibel, Daniel Petras, Jörn Piel, Anna L Vagstad, Silja Mordhorst
Förderung
- Federal Ministry of Education and Research
- Baden-Württemberg Ministry of Science
- Alexander von Humboldt foundation
- Margarete-von-Wrangell program
- European Social Fund Plus
- Deutscher Akademischer Austauschdienst
Zitieren
APA
Pfeiffer, I. P., Schröder, M. P., Koutsandrea, P. H., Vitale, G. A., Herrera-Rosero, D., Geibel, C., Petras, D., Piel, J., Vagstad, A. L., & Mordhorst, S. (2025). Peptide Arginases from Cryptic Pathways Install Ornithine Residues in Uncharacterized Members of Orphan RiPP Families. ChemBioChem. https://doi.org/10.1002/cbic.202500658
Vancouver
Pfeiffer IP, Schröder MP, Koutsandrea PH, Vitale GA, Herrera-Rosero D, Geibel C, et al. Peptide Arginases from Cryptic Pathways Install Ornithine Residues in Uncharacterized Members of Orphan RiPP Families. ChemBioChem. 2025. doi:10.1002/cbic.202500658
BibTeX
@article{Pfeiffer2025,
author = {Pfeiffer, Isabel P-M and Schröder, Maria-Paula and Koutsandrea, Panagiota-Hanna and Vitale, Giovanni A and Herrera-Rosero, Daniela and Geibel, Christian and Petras, Daniel and Piel, Jörn and Vagstad, Anna L and Mordhorst, Silja},
title = {Peptide Arginases from Cryptic Pathways Install Ornithine Residues in Uncharacterized Members of Orphan RiPP Families},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202500658}
}
EUVIMED